Hongbo Lu
InvestorManaging Partner at Lilly Asia Ventures
Palo Alto, California
Writes $10M – $50M checks · typically $25M
FoundedRgenta Therapeutics
Experience
- NEXTBio CapitalManaging Membercurrent2024 — presentMenlo Park, California, United States
- Vivo CapitalManaging Partner2020 — 2024
- Lilly Asia VenturesManaging Partner2017 — 2020San Francisco Bay Area
- OrbiMed AdvisorsManaging Director2011 — 2016
- Piper JaffraySenior Equity Analyst, Principal,2005 — 2011san francisco, california
- Zyomyx, Inc.Technology Planning and Strategies Manager2000 — 2004Hayward, California
Education
- University of California, Berkeley, Haas School of BusinessMBA, Finance2003 — 2005
- University of WashingtonPhD, Bioengineering1995 — 2000
- Tsinghua UniversityBS1988 — 1993
Deals · 81
BlossomHill TherapeuticsBoard seat
via Lilly Asia Ventures · filed Jan 2024 · $100M raise
Rgenta TherapeuticsBoard seat
via Lilly Asia Ventures · filed Mar 2021 · $38M raise
ADARx Pharmaceuticals, Inc.Board seat
via Lilly Asia Ventures · filed Aug 2020 · $5M raise
Perfuse TherapeuticsBoard seat
via Lilly Asia Ventures · filed Jul 2020 · $39M raise
AvedroBoard seat
via Lilly Asia Ventures · filed May 2018 · $25M raise
ArriVent BioPharmaSolo GP
via Lilly Asia Ventures · filed Dec 2022
Sonoma BiotherapeuticsSolo GP
via Lilly Asia Ventures · filed Jul 2021
Terns PharmaceuticalsSolo GP
via Lilly Asia Ventures · filed Dec 2020
KSQ TherapeuticsSolo GP
via Lilly Asia Ventures · filed Sep 2018
NuVera MedicalSolo GP
via Lilly Asia Ventures · filed Jun 2017
AlebundSolo GP
Ansun BiopharmaSolo GP
ConnectbiopharmSolo GP
CorrectsequenceSolo GP
CrownbioSolo GP
Cullinan OncologySolo GP
EdiGeneSolo GP
GeneseeqSolo GP
GracellbioSolo GP
Gritstone OncologySolo GP
HuamaitaikeSolo GP
InhibrxSolo GP
Insilico MedicineSolo GP
InventisbioSolo GP
IonovabioSolo GP
JacobiopharmaSolo GP
Legend BiotechSolo GP
LupengbioSolo GP
LYNK PharmaceuticalsSolo GP
MetacrineSolo GP
MicrotechmdSolo GP
MilliinSolo GP
NiKang TherapeuticsSolo GP
ReadCoorSolo GP
RegorSolo GP
RonatherapeuticsSolo GP
Singleron BiotechnologiesSolo GP
Tempest TherapeuticsSolo GP
Tmunity TherapeuticsSolo GP
中文Solo GP
迪哲医药 (Dizal Pharma)Solo GP
3SbioSolo GP
AbbiskoSolo GP
AceabioSolo GP
AirdocSolo GP
Allist.ComSolo GP
ArmobioSolo GP
AusunpharmSolo GP
BettapharmaSolo GP
Black Diamond Therapeutics, IncSolo GP
BrbiotechSolo GP
CansinotechSolo GP
CarsgenSolo GP
ChinesepeptideSolo GP
ChipscreenSolo GP
ElpiscienceSolo GP
Fountain MedSolo GP
GeneceptionSolo GP
IMPACT TherapeuticsSolo GP
Innovent BiologicsSolo GP
JustbiochinaSolo GP
MabspacebioSolo GP
MediTrust HealthSolo GP
NewhorizonbioSolo GP
NovastSolo GP
PinsmedicalSolo GP
Profound BioSolo GP
RemegenSolo GP
Singlera.ComSolo GP
SinqiSolo GP
SperogenixSolo GP
SzyhloSolo GP
TargetingoneSolo GP
Turning Point TherapeuticsSolo GP
VirtuedxSolo GP
visit ww.nextcure.comSolo GP
visit www.hdbiosciences.comSolo GP
XihuasciSolo GP
凯因科技Solo GP
博瑞医药Solo GP
圣湘生物Solo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Where does Hongbo Lu work?
- Hongbo Lu is Managing Partner at Lilly Asia Ventures.
- What check size does Hongbo Lu write?
- Hongbo Lu typically writes checks of $10M – $50M.
- What companies did Hongbo Lu found?
- Hongbo Lu founded Rgenta Therapeutics.
Same school
Also attended University of California, Berkeley, Haas School of Business583
+ 577 more
Also attended University of Washington262
+ 256 more
Also attended Tsinghua University145
+ 139 more
Shared employers
Also worked at Vivo Capital18
+ 12 more
Also worked at Lilly Asia Ventures2
Also worked at OrbiMed Advisors48
+ 42 more
Also worked at Piper Jaffray58
+ 52 more